Jpmorgan Chase & CO Nutri Band Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Nutri Band Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12 shares of NTRB stock, worth $59. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 18
33.33%
Holding current value
$59
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NTRB
# of Institutions
18Shares Held
284KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA118KShares$585,5920.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.1KShares$287,9920.0% of portfolio
-
Ubs Group Ag20.4KShares$100,9450.0% of portfolio
-
Avantax Advisory Services, Inc.18.7KShares$92,6420.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$85,6390.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $38.7M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...